- Capomulin, far and away, was the best performing drug listed within the report.
-  While Infubinol was one of the better performers in our report regarding 
	metastatic spread during treatment and tumor response, its survival rate 
	over days was the pooreset performing drug.
- closest change in Tumor Volume change between Capomulin and the next best performing 
	drug is 65% - which was Infubinol
